The effect Dehydroepiandrosterone (DHEA) supplementation on IVF outcome
Phase 2
- Conditions
- Female infertility.Female infertility
- Registration Number
- IRCT20160523028008N14
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Candidates for IVF over 35 years
Body mass index between 18 and 25 (kg/m^2)
FSH hormone levels less than 10 IU /
Exclusion Criteria
Systemic diseases such as diabetes, thyroid diseases
History of ovarian surgery
History of receiving DHEA
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy rate. Timepoint: Fourth week after intervention. Method of measurement: Based on Beta-HCG and ultrasound confirmation.;Chemical pregnancy rate. Timepoint: The second week after the intervention. Method of measurement: Based on Beta-HCG a confirmation.;Miscarriage rates. Timepoint: Before 6 and 20 weeks after the intervention. Method of measurement: File.;Endometrial thickness before embryo transfer. Timepoint: Before embryo transfer. Method of measurement: Using ultrasound.;Duration of stimulation. Timepoint: Time required for follicle growth. Method of measurement: Using ultrasound.
- Secondary Outcome Measures
Name Time Method